Abstract
Abstract
Objective
The present study was conducted to compare the effectiveness of transdiagnostic treatment (UP) with the acceptance and commitment therapy (ACT) on the emotional disorders, rumination, and life satisfaction in the patients with irritable bowel syndrome (IBS).
Method
The present study was a randomized clinical trial with a pre-test and post-test design. Between the winter of 2021 and the end of spring 2022, Taleghani Hospital in Tehran received referrals from the statistical population of IBS patients. Of them, 30 individuals (15 in each group) were chosen by convenience sampling and then randomly allocated to groups. UP (It is emotion-based and intervenes in comorbid symptoms), and ACT treatments were provided to the participants online. The participants in the UP and ACT groups received the desired treatments in eight weekly sessions of 45–60 min.
Results
There was no significant difference between UP pre-test and ACT regarding depression, anxiety, rumination, and life satisfaction (P > 0.05). There was no significant difference between UP and ACT post-test in terms of depression, rumination, and life satisfaction (P > 0.05), but due to anxiety, their difference was significant (P < 0.05). Besides, there was a significant difference between pre-test and post-test phases of UP and ACT regarding depression, anxiety, and rumination (P < 0.05). Still, they had no significant difference regarding life satisfaction (P > 0.05).
Conclusion
Therefore, it is suggested that specialists use UP and ACT as effective psychological treatments for the emotional symptoms of IBS patients to improve psychological symptoms.
Funder
School of Medicine, Shahid Beheshti University of Medical Sciences
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,General Medicine
Reference60 articles.
1. Ford AC, Sperber AD, Corsetti M, Camilleri M. Irritable bowel syndrome. Lancet. 2020;396(10263):1675–88.
2. Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015;313(9):949–58.
3. Jahangiri P, Jazi MSH, Keshteli AH, Sadeghpour S, Amini E, Amini E, Adibi P. Irritable bowel syndrome in Iran: SEPAHAN systematic review No. 1. International journal of preventive medicine. 2012;3(Suppl1):1–9.
4. Akhondi N, Memarmontazareyn S, Saneei P, Hassanzadeh-Keshteli A, Esmaillzadeh A, Adibi P. The association of irritable bowel syndrome and obesity in iranian adults. J Isfahan Med Sch. 2016;34(396):1007–12 Persian.
5. Occhipinti K, Smith JW. Irritable bowel syndrome: a review and update. Clin Colon Rectal Surg. 2012;25(1):46–52.